What's new

Human medicines European public assessment report (EPAR): Capecitabine Accord, capecitabine, Date of authorisation: 20/04/2012, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Capecitabine Accord, capecitabine, Date of authorisation: 20/04/2012, Revision: 19, Status: Authorised

May 5, 2025 - 11:01
 0
Human medicines European public assessment report (EPAR): Capecitabine Accord, capecitabine, Date of authorisation: 20/04/2012, Revision: 19, Status: Authorised
Human medicines European public assessment report (EPAR): Capecitabine Accord, capecitabine, Date of authorisation: 20/04/2012, Revision: 19, Status: Authorised
Read More

Tags:

Previous Article

Faraday Future’s FX brand announces an additional significant pre-order for its ...

Next Article

Poor customer service tops in negative shopping experiences

Related Posts

Human medicines European public assessment report (EPAR): Lynozyfic, linvoseltamab, Date of authorisation: 23/04/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

May 2, 2025  0

Human medicines European public assessment report (EPAR): Regkirona, regdanvimab, Date of authorisation: 12/11/2021, Revision: 9, Status: Withdrawn

Human medicines European public assessment report (EPAR...

Apr 24, 2025  0

European Medicines Agency policy on access to EudraVigi...

May 5, 2025  0